English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, November 28, 2023
American Wave Machines, Inc. Announces Successful Review of Patents
eDriving Launches New EcoReport Sustainability Reporting Solution for Fleets
Thursday, October 5, 2023
CorDx to Launch New Global Brand, CuPet, in Singapore
Wednesday, October 4, 2023
Diamond Equity Research Initiates Coverage on QuantaSing Group Limited (NASDAQ: QSG)
Tuesday, October 3, 2023
ZeptoMetrix Awarded in Vitro Diagnostic Regulation (IVDR) Certification
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101
The World's First AI-Created Digital Children's Spokesperson 'Uni' is Ready to Amplify the Voices of Children Around the World
Monday, March 30, 2020
Dyadic Announces Nonexclusive Research License with WuXi Biologics
Monday, March 16, 2020
Coronavirus Drug Development Update from NanoViricides, Inc.
Thursday, February 27, 2020
NanoViricides has filed Quarterly Report for period ending December 31, 2019; Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress

Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575